Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00036140 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00036140 is a Phase 1 study that has completed, run by Pfizer.
The verdict
NCT00036140, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The primary goal of the study is to determine the best dose of an investigational drug to give to patients with multiple myeloma and to evaluate the investigational drug's effectiveness as a treatment for multiple myeloma.
Interventions
- DRUG Investigational drug
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00036140
The ClinicalTrials.gov registry entry for NCT00036140 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Investigational drug is the first listed.
NCT00036140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00036140 about?
NCT00036140 is a clinical study titled "Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma". The primary goal of the study is to determine the best dose of an investigational drug to give to patients with multiple myeloma and to evaluate the investigational drug's effectiveness as a treatment for multiple myeloma.
What is the current status of trial NCT00036140?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00036140?
The interventions under investigation include: Investigational drug (DRUG).
Who is sponsoring clinical trial NCT00036140?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.